Guizhounli Pharmaceutical Co (SHSE:603439) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603439 Guizhou Sanli Pharmaceutical Co Ltd SHSE:603439
86 GF Score
Price ¥9.93
GF Value ¥14.90
Valuation Significantly Undervalued
! 10 Warning Signs
View Full Analysis

What is Guizhounli Pharmaceutical Co Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

SHSE:603439
86GF Score
Guizhou Sanli Pharmaceutical Co Ltd SHSE:603439
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guizhounli Pharmaceutical Co (SHSE:603439) Overvalued in 2026?

Based on GuruFocus' analysis, Guizhounli Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥9.93 is trading 33.4% below its estimated GF Value™ of ¥14.90. GuruFocus considers Guizhounli Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for SHSE:603439:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ¥14.90 vs. price of ¥9.93 (33.4% below fair value)
  • GF Score™: 86/100 with 10 warning signs

No single metric tells the full story. See the SHSE:603439 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guizhounli Pharmaceutical Co Business Description

Address Xiayun Industrial Park, Pingba District, Guizhou Province, Anshun, CHN, 561000
Guizhou Sanli Pharmaceutical Co Ltd is engaged in Chinese pharmaceutical research, development, production and marketing. The company produces and sells soft capsules, hard capsules, sprays (including Chinese medicine extraction) and provides Chinese medicine science and technology consulting services. Its products include Pediatric medication; Respiratory system medication; Cardiovascular and cerebrovascular drugs; Digestive medicine; Trauma injury medication; Rehabilitation medicine; and Ophthalmic medicine.
86GF Score

Get the complete analysis for SHSE:603439

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.93
Price
¥14.90
GF Value